TL;DR
Turn your wind-down time into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
A Finnish case-control study found that people diagnosed with Alzheimer’s disease before age 65 had a broader range of health problems and increasing healthcare use in the years before diagnosis. The study found no significant difference in morbidity 11 to 15 years beforehand and no greater prevalence of high blood pressure or high cholesterol than among matched controls.
A study led by researchers at the University of Oulu and the University of Eastern Finland found that people diagnosed with Alzheimer’s disease before age 65 tended to accumulate a range of health problems and make greater use of healthcare services as diagnosis approached. The findings, based on Finnish health records, may help clinicians recognize patterns that warrant further assessment, but the researchers stress that no single symptom or condition predicts the disease.
The researchers examined conditions recorded during the 15 years before diagnosis among 407 people with early-onset Alzheimer’s disease. They compared those records with data from more than 4,000 age- and sex-matched controls who did not have a neurodegenerative disease. The patient information came from memory clinics at Oulu University Hospital and Kuopio University Hospital, linked with nationwide health-register data.
Compared with controls, people later diagnosed with early-onset Alzheimer’s were more likely to have records of depression, dizziness, headaches, traumatic brain injuries, epilepsy and cerebrovascular disorders, as well as thyroid diseases and problems related to heavy alcohol use. Tinnitus and hearing loss were more common as early as six to 10 years before diagnosis. The study found no significant differences in overall morbidity 11 to 15 years before diagnosis; differences became more apparent nearer to diagnosis, particularly in the final five years.
Healthcare use also rose during that period, with the steepest increase in visits in the final year before diagnosis. The researchers reported that high blood pressure and hyperlipidemia were not more common among the early-onset Alzheimer’s group than among controls. The study was published in the journal Alzheimer’s & Dementia under the title “Comorbidities and health-care use prior to early-onset Alzheimer’s disease: A population-based case–control study.”
Patterns Before Working-Age Diagnosis
Early-onset Alzheimer’s affects people who are still below the conventional age threshold of 65, and identifying it can be difficult when health changes appear as separate problems rather than as an obvious memory disorder. The study’s findings suggest that a growing mix of conditions and healthcare encounters may be part of the picture in the years before a diagnosis. That pattern could prompt closer consideration of cognitive or neurological causes when appropriate, rather than treating each issue as an isolated clue.
The results do not establish that these conditions cause Alzheimer’s or that tracking them can identify who will develop it. Depression, headaches, hearing loss and the other conditions are common and have many possible explanations. The researchers say the value may lie in recognizing an overall pattern, not treating any individual symptom as a warning sign. Better recognition could matter to working-age patients and families facing delays in getting an explanation for persistent changes.
Popular right now

Apple AirPods Pro 3 Wireless Earbuds with Active Noise Cancellation

Ninja CREAMi 7-in-1 Ice Cream Maker, NC299AMZ

Breville Bambino Espresso Machine, Brushed Stainless Steel (BES450BSS)
As an affiliate, we earn on qualifying purchases.
How the Finnish Records Were Compared
The research team used a population-based case-control design, comparing people with early-onset Alzheimer’s against controls matched for age and sex. It looked backward from diagnosis across three broad periods: 11 to 15 years, six to 10 years, and the final five years. This timeline allowed the researchers to examine when differences in recorded health conditions and healthcare use became more apparent.
The study also addresses whether early-onset Alzheimer’s resembles the better-known late-onset form in its associated health profile. Advanced age and cardiovascular conditions are commonly discussed as risk factors for Alzheimer’s overall. In this study, however, high blood pressure and hyperlipidemia were not more prevalent in the early-onset group than in matched controls. Lead investigator Adjunct Professor Johanna Krüger said the findings support the view that early-onset Alzheimer’s is not simply a younger-age version of late-onset disease. That interpretation is a conclusion drawn from the study’s observed differences, not proof of a distinct biological mechanism.
“No single disease or symptom predicts Alzheimer’s disease.”
— Laura Leppänen, University of Oulu doctoral researcher and first author
What Symptoms Can’t Establish
The study shows associations in recorded health histories; it does not demonstrate that the listed conditions cause Alzheimer’s, result from it, or reliably signal that an individual will develop it. The source material does not report that the researchers tested a prediction tool or measured whether using these patterns would shorten diagnostic delays. No single condition was identified as a diagnostic predictor, and the findings cannot be used on their own to diagnose early-onset Alzheimer’s.
The analysis was based on patients diagnosed through two Finnish hospital memory clinics and linked national registers. The supplied report does not provide detailed figures for each condition, the size of the healthcare-use increase, or information about how well the results would apply in other countries and health systems. It also remains unclear which observed conditions preceded disease-related changes and which may have other explanations.
From Association to Earlier Recognition
The study’s authors say the findings point to a need to identify dementia and Alzheimer’s disease among working-age adults earlier. The next practical step would be further research into whether combined health-history patterns can help clinicians recognize who may benefit from a more focused cognitive assessment. The study itself does not establish a screening method or recommend that people with any listed symptom undergo testing.
Further work would also need to test the findings in other populations and clarify how often these patterns occur among people who do not develop Alzheimer’s. For now, the report adds evidence about health conditions and healthcare use before diagnosis, while clinical evaluation remains necessary to determine the cause of an individual’s symptoms. People with concerns about changes in memory, thinking or daily functioning should discuss them with a qualified health professional.
Key Questions
What did the study find before early-onset Alzheimer’s diagnosis?
It found that people diagnosed before age 65 had a wider range of recorded health conditions and greater healthcare use as diagnosis approached, with differences most apparent in the five years beforehand.
Which conditions were more common in the study group?
Compared with matched controls, the group had more records of depression, dizziness, headaches, traumatic brain injuries, epilepsy, cerebrovascular disorders, thyroid diseases and problems related to heavy alcohol use. Tinnitus and hearing loss were more common six to 10 years before diagnosis.
Do these symptoms mean someone has Alzheimer’s?
No. The study did not establish that any single condition predicts Alzheimer’s. These health problems can have many causes, and the reported associations are not a diagnostic test.
Were cardiovascular risk factors more common?
In this study, high blood pressure and hyperlipidemia were not more common among people with early-onset Alzheimer’s than among age- and sex-matched controls.
How many people were included?
The researchers studied 407 people with early-onset Alzheimer’s and compared their records with those of more than 4,000 matched controls, using Finnish hospital and nationwide health-register data.
Source: rss
